Latest Breaking News On - Clinical trial application - Page 10 : comparemela.com

Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes

BMF-219 is a novel investigational covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes Health Canada has cleared the initiation of.

Juan pablo friasBiomea fusion incExchange commissionSecurities exchangeHealth canadaClinical trial applicationBiomea fusionChief medicalSecurities actSecurities exchange actExchange act

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South africaMark emalfarbJulian naidooUniversity of the witwatersrandRubic one healthDyadic international incWits health consortiumAfrican health products regulatory authorityDyadic internationalSecurities exchangeSerious adverse eventsClinical study reportClinical trial applicationChief executive officerOne healthSecurities act

Dyadic International, Inc (DYAI) Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Dyadic International, Inc (DYAI) Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South africaJulian naidooMark emalfarbAfrican health products regulatory authorityDyadic international incRubic one healthDyadic internationalClinical trial applicationSerious adverse eventsChief executive officer

INmune Bio Receives EMA s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer s Disease

INmune Bio Receives EMA s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer s Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boca ratonUnited statesUnited kingdomJason nelsonDavid mossMedicamentosy productos sanitariosInmune bioDrug administrationCompany clinical trial applicationCompany current reports on formExchange commissionCompany quarterly reports on formInmune bio incCompany annual report on formEuropean medicines agencyGlobe newswire inmune bio inc

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation – Padovanews

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomRyan protzkoHans juergen grussJohn boghossianKanna health investigational new drugRegulatory agencyContract research organizationKanna health ltdKanna healthDrug administrationUnited kingdom medicinesInvestigational new drugClinical trial applicationHealthy maleChief medical